Article: Gan-Qing-Ning Formula Inhibits the Growth of Hepatocellular Carcinoma by Promoting Apoptosis and Inhibiting Angiogenesis in H
Evidence-based complementary and alternative medicine : eCAM
2020 Volume 2020, Page(s) 6376912
Abstract: Objective: Gang-Qing-Ning (GQN) is a traditional Chinese medicine formula that has been used in the treatment of hepatocellular carcinoma (HCC) in the folk population for decades. However, scientific validation is still necessary to lend credibility to ... ...
Abstract | Objective: Gang-Qing-Ning (GQN) is a traditional Chinese medicine formula that has been used in the treatment of hepatocellular carcinoma (HCC) in the folk population for decades. However, scientific validation is still necessary to lend credibility to the traditional use of GQN against HCC. This study investigates the antitumor effect of GQN on H Methods: Fifty H Results: The tumor inhibitory rates of high, medium, and low dosages of GQN groups were 47.39%, 38.26%, and 22.17%, respectively. The high dosage of the GQN group significantly increased the protein and mRNA expression levels of Bax, Cyt-C, and cleaved Caspase 3 (or Caspase 3) ( Conclusions: The high dosage of GQN can significantly inhibit the tumor growth in H |
|||||
---|---|---|---|---|---|---|
Language | English | |||||
Publishing date | 2020-08-06 | |||||
Publishing country | United States | |||||
Document type | Journal Article | |||||
ZDB-ID | 2171158-6 | |||||
ISSN | 1741-4288 ; 1741-427X | |||||
ISSN (online) | 1741-4288 | |||||
ISSN | 1741-427X | |||||
DOI | 10.1155/2020/6376912 | |||||
Shelf mark |
|
|||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5995: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.